Clinical Trial Update: Phase II Randomized Study of Hypofractionated Versus Conventional Radiotherapy [NA]

View source ↗

Summary

Phase II randomized trial comparing hypofractionated radiotherapy with conventional radiotherapy for laryngeal carcinoma; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Laryngeal Carcinoma

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Laryngeal Carcinoma | NA | Status: RECRUITING